Generics - Pharmaceutical sciences

Filter

Current filters:

Pharmaceutical sciences

Popular Filters

Alvogen acquires Korean Dream Pharma for $187 million

Alvogen acquires Korean Dream Pharma for $187 million

06-08-2014

Privately-owned US generics firm Alvogen says it has acquired Dream Pharma in South Korea for $187 million…

AlvogenApac DistrictAsia-PacificBusiness FinanceDream PharmaGeneric pharmaceuticalGenericsMergers & AcquisitionsNorthern Region, UgandaPharmaceutical sciences

Actavis files for generic version of Acorda’s Ampyra

Actavis files for generic version of Acorda’s Ampyra

27-06-2014

US biotech firm Acorda Therapeutics has been advised that Ireland-headquartered generics major Actavis…

Acorda TherapeuticsActavisAmpyraGenericsHealth Medical PharmaMedicinePharmaceutical sciencesPharmacologyRegulationUS Food and Drug AdministrationUSA

US health care providers have concerns on proposed FDA generic drug labeling rules

US health care providers have concerns on proposed FDA generic drug labeling rules

19-06-2014

A survey co-released today by the USA’s Generic Pharmaceutical Association (GPhA) and the National…

GenericsHealth Medical PharmaHealthcareMedicinePharmaceutical sciencesPharmacologyPhysicianRegulationUSA

Mylan settles over generic Generess tablets and launches insomnia drug

Mylan settles over generic Generess tablets and launches insomnia drug

16-04-2014

US generics major Mylan (Nasdaq: MYL) and its partner Famy Care have entered into a settlement and license…

ActavisFamy CareGeneress FeGenericsHealth Medical PharmaLegalLunestaMylanMylan LaboratoriesPharmaceutical sciencesPharmacologyUSAWomen's Health

Back to top